Sana Biotechnology, Inc.
General ticker "SANA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $715.5M (TTM average)
Sana Biotechnology, Inc. follows the US Stock Market performance with the rate: 57.0%.
Estimated limits based on current volatility of 4.4%: low 3.62$, high 3.96$
Factors to consider:
- Earnings expected soon, date: 2026-03-16 bmo
- Total employees count: 194 (-40.9%) as of 2024
- Top business risk factors: Operational and conduct risks, Supply chain disruptions, Labor/talent shortage/retention, Stem cell supply risks, Market competition
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.36$, 4.01$]
- 2025-12-31 to 2026-12-31 estimated range: [1.40$, 3.87$]
Financial Metrics affecting the SANA estimates:
- Positive: with PPE of -1.5 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -57.60 <= 0.01
- Positive: Investing cash flow per share per price, % of 4.50 > -0.63
- Positive: 42.68 < Shareholder equity ratio, % of 50 <= 64.29
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term SANA quotes
Long-term SANA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $272.56MM | $293.14MM | $272.72MM |
| Operating Income | $-272.56MM | $-293.14MM | $-272.72MM |
| Non-Operating Income | $3.09MM | $9.89MM | $5.96MM |
| R&D Expense | $285.88MM | $268.82MM | $217.56MM |
| Income(Loss) | $-269.48MM | $-283.25MM | $-266.76MM |
| Profit(Loss)* | $-269.48MM | $-283.25MM | $-266.76MM |
| Stockholders Equity | $499.31MM | $287.51MM | $250.50MM |
| Assets | $822.72MM | $565.30MM | $501.02MM |
| Operating Cash Flow | $-290.05MM | $-253.58MM | $-223.15MM |
| Capital expenditure | $20.88MM | $20.03MM | $33.43MM |
| Investing Cash Flow | $210.56MM | $172.01MM | $17.45MM |
| Financing Cash Flow | $4.91MM | $31.65MM | $199.75MM |
| Earnings Per Share** | $-1.43 | $-1.46 | $-1.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.